microINR coagulation monitor listed by Austrian health insurances

Since autumn 2022, the microINR system has been acknowledged by the Austrian health insurances and the costs are covered in certain cases. There are two versions: the professional version for point-of-care and the system for patient self-management.

People who are permanently treated with oral anticoagulants made of coumarin derivatives (vitamin K antagonists) due to a disease have the possibility to control their coagulation values themselves with the microINR and, if necessary, to make dose adjustments of their medication.

For appropriate indications such as heart valve replacement, atrial fibrillation or follow-up after cardiovascular events such as myocardial infarction or deep vein thrombosis, Austrian health insurers now also cover the costs of this patient self-monitoring.

The prerequisite for this is not only the correct prescription with medical justification but also participation in a qualified training course. This involves learning the basics of blood coagulation, the practical use of the microINR device and the dosage adjustment of the medication.

At Axonlab, we qualify and certify you and your team to conduct self-management training and provide you with all the necessary documentation.

Interested? Contact us by phone 05238 87766 or by e-mail info@axonlab.at